SLC2A3 and melanoma: As melanoma is less responsive to the existing therapeutic approach, our observations provide a new insight into the role of GLUT subtypes, GLUT1 and GLUT3, in cell growth and highlight an anti-glycolytic strategy as a promising tool for the treatment of canine melanoma.